Areas of interest

COVID-19 Endometriosis Inflammation and cancer Inflammatory bowel disease (IBD) Influenza Lung cancer Microbiome in health and disease Ovarian cancer

Research group

Regulation of Interferon and Innate Signalling

Biography

Dr Edward Giles joined CiiiD in February 2016 as a clinician-scientist and performs research on the mucosal immunology of inflammatory bowel diseases (IBD), particularly the role of type I interferons and their influence on the adaptive immune system and microbiome of the intestine.

At the same time, Dr Giles has an appointment as a Consultant Paediatric Gastroenterologist at the Monash Children’s Hospital of the Monash Health network, where he is lead for paediatric IBD and has established a specific clinic for young adult patients with inflammatory bowel diseases in close collaboration with Dr Greg Moore, head of adult IBD at Monash Health. This is a unique clinical service in Victoria and is modelled on a clinic Dr Giles ran jointly in the UK.

He is a Fellow of the Royal Australasian College of Physicians and was awarded his PhD on Type I Interferon Signaling in human intestinal T Cells from the University of London in 2015. In 2017, he was appointed to the Gastroenterological Society of Australia (GESA) research committee.